1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Regulation

Danish Retail Group Blacklists Cosmetics With PFAS; Australian Animal-Testing Ban; More Cosmetics News

 
• By Ryan Nelson

Cosmetics containing fluorinated compounds are no longer welcome in Coop Denmark’s 1,050 stores or its e-commerce platform. Meanwhile, consumer group BEUC proposes changes to the European Cosmetics Regulation to address endocrine-disrupting chemicals, and Australia passes legislation to bar new, cosmetics-only chemicals from market if their safety substantiation relies on animal testing.

3d render of Europe map Earth globe

The leading consumer goods retailer in Denmark, Coop Danmark A/S, announced March 9 that it will no longer be purchasing cosmetic products containing per- and polyfluoroalkyl substances (PFAS), including from international brands, due to concerns about cancer, endocrine disruption and other health risks linked to the ingredient group. (Also see "Personal-Care Ingredient News In Brief: UC Berkeley Study Makes Waves; PFAS In Cosmetics; More" - HBW Insight, 11 December, 2018.) “We have a great focus on protecting our customers from exposure to chemical substances that can contribute to a harmful cocktail effect. By taking the lead, we hope that the entire international beauty industry can be encouraged to find better alternatives,” says Coop Quality Manager Malene Teller Blume. The decision, effective immediately, means that PFAS-containing cosmetics will vanish by mid-September from coop.dk and Coop retail chains – including Kvickly, SuperBrugsen, Dagli’Brugsen and subsidiaries fakta A/S and Irma A/S – which in sum account for 1,050 stores across Denmark and DKK 50bn in annual turnover, according to the release.

European consumer-advocacy group BEUC is convinced that changes are needed to the Cosmetics Regulation in order for endocrine-disrupting chemical (EDC)...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

Animal Studies Would Not Provide ‘Meaningful Insights’ Into UV Filter Safety - Study

 
• By Lauren Nardella

A new study on the safety of sunscreen filters relies on an alternative assessment methodology and concludes that six sunscreen UV filters are unlikely to be carcinogenic.

EU’s Small, Medium Beauty Industry Pushing For Clarity In Revised CPR

French SME association COSMED will push the European Commission for a “clear checklist” and criteria on how substances in the Cosmetic Products Regulation are assessed by Member States, as well as more clarity on the exemption process and timelines.

US FDA Expert Panel Paints Bleak Picture For Future Of Talc In Cosmetics

 
• By Eileen Francis

The US FDA’s 20 May expert panel on talc discussed science behind the potential carcinogenicity of the cosmetic, food and drug ingredient, the importance of ‘good science’ in evaluating the substance and the need to find alternatives in each industry.

More from Policy & Regulation

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

IBA Interactive Policy Map Is Call To Action As Cosmetics Industry Braces For Myriad Of State Bills

 
• By Eileen Francis

The Independent Beauty Association has launched an interactive Policy Map tracking state and federal bills and filtering by state or topic, pinpointing bills of great priority.